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Protozoan Kinetoplastida such as the pathogenic trypanosomes compartmentalize several important metabolic systems, including the
glycolytic pathway, in peroxisome-like organelles designated glycosomes. Genes for three proteins involved in glycosome biogenesis of
Trypanosoma brucei were identified. A preliminary analysis of these proteins, the peroxins PEX6, PEX10 and PEX12, was performed. Cellular
depletion of these peroxins by RNA interference affected growth of both mammalian bloodstream-form and insect-form (procyclic) trypanosomes.
The bloodstream forms, which rely entirely on glycolysis for their ATP supply, were more rapidly killed. Both by immunofluorescence studies of
intact procyclic T. brucei cells and subcellular fractionation experiments involving differential permeabilization of plasma and organellar
membranes it was shown that RNAi-dependent knockdown of the expression of each of these peroxins resulted in the partial mis-localization of
different types of glycosomal matrix enzymes to the cytoplasm: proteins with consensus motifs such as the C-terminal type 1 peroxisomal
targeting signal PTS1 or the N-terminal signal PTS2 and a protein for which the sorting information is present in a polypeptide-internal fragment
not containing an identifiable consensus sequence.
D 2005 Elsevier B.V. All rights reserved.Keywords: Trypanosoma; Glycosome biogenesis; Peroxin; RNA interference1. Introduction
Trypanosomes are parasitic organisms belonging to the
protozoan order Kinetoplastida. All members of this taxonomic
group possess a number of distinctive structural and metabolic
properties such as the presence of peculiar organelles. The
unique organelles comprise the kinetoplast, a subcompartment0167-4889/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2005.11.002
Abbreviations: ALD, aldolase; ENO, enolase; gGAPDH, glycosomal
glyceraldehyde-3-phosphate dehydrogenase; PEX, peroxin; PTS, peroxisome-
targeting signal; PYK, pyruvate kinase; TIM, triosephosphate isomerase
i The new nucleotide sequence data reported in this paper are available in the
DDJB/EMBL/GenBank databases under the accession numbers DQ226512
(PEX6), DQ226513 (PEX10) and DQ226514 (PEX12). (2) Slightly different
systems are being used for abbreviations of proteins and genes in research on
peroxisomes/glyoxysomes/glycosomes in mammals, plants, yeasts and proto-
zoa. Throughout this paper, we used the official nomenclature system for
trypanosomatid protozoa (upper case for proteins, italicized upper case for
genes) [58].
* Corresponding author. Tel.: +32 2 764 74 73; fax: +32 2 762 68 53.
E-mail address: michels@bchm.ucl.ac.be (P.A.M. Michels).of the single mitochondrion containing DNA uniquely orga-
nized and expressed [1–3], and glycosomes, peroxisomes
which have as their most distinctive feature the presence of the
majority of the enzymes of the glycolytic pathway [4,5]. In
other organisms, glycolysis occurs in the cytosol. In addition to
glycolytic enzymes, the glycosomes may contain enzymes or
(parts of) other pathways, such the gluconeogenic and
pentosephosphate pathways, pyrimidine biosynthesis and
purine salvage, and in common with peroxisomes in other
eukaryotes, enzymes of peroxide metabolism, fatty-acid
oxidation and ether-lipid biosynthesis [4]. The classification
of glycosomes within the organelle family of peroxisomes, also
including yeast microbodies, plant glyoxysomes and fungal
Woronin bodies, is further based on the fact that all these
organelles have a single boundary membrane, contain no DNA,
and follow similar routes of biogenesis [4–7].
The matrix proteins of the organelles are encoded by nuclear
genes, synthesized on free ribosomes in the cytosol and post-
translationally imported usually without any detectable form of
processing. Previous research, mainly performed on differentta 1763 (2006) 6 – 17
http://www
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can conveniently be considered as comprising a number of
distinct steps [6–11]. (1) Recognition of the proteins by a
receptor; (2) docking of the receptor with its bound cargo on
the membrane; (3) membrane translocation of the receptor–
protein complex; (4) cycling of the discharged receptor back to
the cytosol. The process is mediated by proteins called
peroxins, abbreviated PEX. In the first step, two different
cytosolic receptors, PEX5 and PEX7 recognize proteins to be
imported through their peroxisome-targeting signals, PTS1 and
PTS2, respectively. PTS1 is the most commonly used signal; it
consists of a C-terminal tripeptide -SKL or a sequence of
amino acids with similar physico-chemical properties. Yet, the
¨10 residues preceding the tripeptide may to some extent
affect the efficiency of import. PTS2 is a less frequently used
signal; it comprises a nonapeptide motif—(R/K)(L/H/
V)X5(QH)(LA)—close to the N-terminus of the protein. Some
peroxisomal proteins do not have a PTS1 or PTS2, but may use
either a non-conserved sequence, often internal to the
polypeptide (I-PTS), to interact with PEX5 or PEX7, or enter
by forming a heteromeric complex with PTS1- or PTS2-
bearing proteins (Fpiggy-backing_). Indeed, it has been shown
that peroxisomal proteins may enter the organelle in folded and
even oligomeric form [12]. The cargo–receptor complex,
possibly even in conjunction with auxiliary proteins, interacts
with the membrane through a docking complex minimally
comprising PEX13 and PEX14. The complex is then trans-
ported through the membrane, probably mediated by the so-
called translocation complex of integral membrane RING-
finger proteins, PEX2, PEX10 and PEX12, followed by cargo
release at the matrix side of the membrane. Although the notion
that the receptor moves through the membrane is generally
accepted, some controversy exists as to whether it effectively
enters the matrix or only releases the cargo at the membrane’s
inner surface [8]. But consensus exists that the receptors PEX5
and PEX7 return to the cytosol, mediated minimally by an
integral membrane protein (PEX15 in yeast or the non-
homologous PEX26 in mammalian cells) and two soluble
peroxins belonging to the AAA+ protein family, PEX1 and
PEX6. Several recently reported observations suggest that
mono- or di-ubiquitylation of the import receptors functions as
a signal for PEX1 and PEX6 to transfer them back to the
cytosol [reviewed in [11]]. It should be noted that an alternative
function invoked for the RING-finger proteins PEX2, PEX10
and PEX12 is an involvement in this return of the receptors to
the cytosol, rather than in the import of the receptor–cargo
complex [10]. In this respect, it is important to note that RING-
finger domains are characteristic elements of E3-ubiquitin
ligases.
The first two steps of the process by which proteins are
imported into the glycosomal matrix of the kinetoplastids
Trypanosoma brucei and Leishmania donovani have already
received some attention in previous research. Cloning and
characterization of PEX5 and PEX14 of these parasites have
been reported, and the interaction between these peroxins and
with PTS1 proteins has been studied in detail [13–20]. Also,
the importance of these peroxins for proper compartmentationof glycosomal enzymes, and for trypanosomatid metabolism
and viability has been analyzed [17,21,22]. In contrast, little is
known about the peroxins involved in later steps of import of
glycosomal matrix proteins. Only studies on trypanosomatid
PEX2 homologues have been reported [23–26].
Here, we present our work on the identification and
preliminary characterization of three T. brucei proteins
homologous to peroxins involved in the third and fourth steps
of import of proteins into the peroxisomal matrix: PEX10 and
PEX12, presumably responsible for the translocation process,
and PEX6, involved in receptor cycling. Moreover, we provide
evidence that indeed these trypanosomal proteins are essential
for proper glycosome biogenesis.
2. Materials and methods
2.1. Trypanosomes and growth conditions
Bloodstream and procyclic form T. brucei 427, cell line 449 [27],
constitutively expressing the Escherichia coli tetracycline repressor gene
integrated in its genome, were used in this study. Bloodstream forms were
cultured in HMI-9 medium containing 10% heat-inactivated foetal calf serum
(Invitrogen) and 0.2 Ag mL1 phleomycin (Cayla), the selectable marker for the
tetracycline repressor construct, at 37 -C under water-saturated air with 5%
CO2. Procyclic trypanosomes were grown in normal SDM-79 medium [28]
supplemented with 10% foetal calf serum and 0.5 Ag mL1 phleomycin at 28
-C under water-saturated air with 5% CO2. Cultures were always harvested in
the exponential growth phase, i.e., at densities lower than 2  106 cells mL1
for bloodstream forms and 1  107 cells mL1 for procyclic cells, by
centrifugation at 1900g for 10 min.
2.2. Identification of sequences for the trypanosomatid homologues of
peroxins PEX6, PEX10 and PEX12
The database of the T. brucei (strain TREU927/4) genome project, when
still at a stage of partial completion, was searched for sequences homologous to
those of various yeast and mammalian peroxins. Short fragments of putative
candidates were identified in searches performed with PEX6, PEX10 and
PEX12 sequences. The corresponding fragments were amplified from genomic
DNA of T. brucei strain 427, using Taq DNA polymerase (TaKaRa), ligated in
the pGEM-T Easy vector (Promega), cloned and sequenced with a Beckmann
CEQ2000 apparatus (Beckman Instruments, Inc.) using the CEQ DTCS Dye
Terminator Cycle sequencing kit (Amersham Biosciences). A purified
recombinant plasmid was then used as a probe to screen a genomic T. brucei
427 library prepared in E. coli strain MB406 with phage EGEM11 [29].
Positive clones were isolated, and DNA fragments subcloned and sequenced.
Protein sequences were aligned using the program Clustal W [30].
2.3. Molecular biological methods
For most experiments in molecular biology standard methodologies were
used [31], or protocols were followed as provided by suppliers of enzymes used
for various forms of DNA and RNA manipulation (Fermentas, Roche Applied
Science, New England Biolabs, Promega, Invitrogen, TaKaRa). E. coli strain
XL-1-Blue (Stratagene) was used for all plasmid cloning.
2.4. Construction of expression systems, purification of recombinant
proteins, and antiserum production
Truncated versions of T. brucei 427 PEX6 (993 bp from positions 1956 to
2949 and 1014 bp from 1935 to 2949, both constructs comprising the AAA
motifs D1 and D2) were amplified by PCR using Invitrogen Platinum Pfx DNA
polymerase, a sense oligonucleotide containing an NdeI restriction site just
upstream of the chosen (or introduced) ATG start codon and an antisense
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products were purified, cloned using the vector pGEM-T Easy and, after
checking their sequence, excised from the recombinant plasmid by digestion
with NdeI and BamHI and ligated to the expression plasmid pET28a
(Novagen), digested with the same enzymes. Each plasmid directs the synthesis
of a PEX construct with an N-terminal, 20 residues long extension including six
successive His residues (FHis6-tag_). E. coli strain BL21(DE3) cells were
transformed with these constructs.
Cells harbouring a recombinant plasmid for expression of truncated PEX6
were grown in 400 mL or 1 L TB medium [31] supplemented with 30 Ag mL1
kanamycin at 37 -C. Once the culture had reached an OD600 nm of 0.7–0.9, the
temperature was reduced to 15 -C and 1 h later isopropyl h-d-thiogalactano-
pyranoside was added to a final concentration of 1 mM to induce expression of
recombinant protein and growth was continued for 15–16 h. Protein
purifications were performed at 0–4 -C. Cells were harvested by centrifugation
(5000g, 15 min), resuspended in 20–40 mL of cell lysis buffer containing
100 mM triethanolamine/HCl, pH 8, 1 M NaCl, 10% glycerol and a complete
protease inhibitor cocktail (Roche Applied Science). Cells were disrupted by
three passages through a SLM-Aminco French pressure cell (SLM Instruments,
Inc.) at 90 MPa. Nucleic acids were degraded by incubation of the lysate with
100 units of Benzonase (Merck) for 30 min at 37 -C. Cell debris and insoluble
material were then removed by centrifugation (10,000g, 15 min). To the
supernatant was then added 10 mM imidazole and 0.125–0.25 volumes of
Talon Metal Affinity Resin (BD Biosciences-Clontech) and the suspension was
mixed for 30 min at room temperature. The resin with bound protein was
washed twice with five column volumes of lysis buffer containing 70 mM
imidazole, followed by elution of the peroxin using three column volumes of
the same buffer containing 200 mM imidazole. Purification was checked by
SDS-PAGE followed by Coomassie Blue staining or immunodetection after
preparation of Western blots and using a mouse anti-His antiserum (see below).
The purified truncated PEX6 polypeptides were used to raise polyclonal
antisera in rabbits (Eurogentec). The anti-PEX6 sera were highly specific, as
they were able to detect only a single band on Western blots of whole cell
lysates of T. brucei cells.
Attempts to express in soluble form, and/or to purify the entire PEX6 and
PEX12 proteins, and a truncated version of PEX12 remained unsuccessful.
PEX10 was expressed and purified as a recombinant protein, and a rabbit
antiserum was raised, but experiments conducted to determine the specificity of
this antiserum were non-conclusive.
2.5. RNA interference studies
The T. brucei-specific vector pHD677 [27] was used to generate stable
bloodstream and procyclic cell lines for the tetracycline-inducible expression of
a double-stranded RNA of PEX6, PEX10 and PEX12. Double-stranded RNAs
were produced as hairpin molecules by transcription of constructs comprising
two similar fragments of the coding regions of each gene, one somewhat longer
than the other, arranged as a direct inverted repeat. These constructs were
prepared by amplification of fragments for PEX6 (sense: nucleotides from
positions 798 to 1488, antisense: nucleotides 793 to 1406), PEX10 (sense:
nucleotides 22 to 885, antisense: nucleotides 10 to 807) and PEX12 (sense:
nucleotides 28 to 840, antisense: nucleotides 19 to 774), using appropriate
primers. All RNAi constructs were prepared for chromosomal integration in the
transcriptionally silent ribosomal RNA gene repeat spacer.
For transfection of bloodstream-form trypanosomes, 10–15 mL of culture
was harvested at a density of ¨1.6  106 cells mL1, washed once with 5 mL
cytomix [32] and resuspended in the same solution. The trypanosome
suspension (0.4 mL, containing 1  107 cells mL1) was incubated with 10
Ag DNA linearized by digestion with NotI, and subsequently subjected to a
single discharge by a Genetronics BTX ECM630 electroporator with a 1.25 kV,
25 Ohm and 50 AF setting, to obtain a pulse with a time constant of ¨260 As.
The cells were diluted in 12 mL culture medium, supplemented with 20% foetal
calf serum, and incubated overnight. Subsequently, the culture was split into 24
wells of a microtiter plate. To select positive transfectants, hygromycin (Sigma)
was added after 24 h at a final concentration of 5 Ag mL1. Antibiotic-resistant
cells were detectable after about 5 days.
To create stable transfectants of procyclic forms, 3–8 mL of a culture at a
density of 4–8  106 cells mL1 were centrifuged, washed once in 2 mL ice-cold Zimmerman Post-Fusion Medium [33], and resuspended in this medium.
2–3  107 cells in 0.5 mL together with 10 Ag of linearized DNA were
incubated for 10 min on ice, in a 4 mm electroporation cuvette. Cells were then
subjected to a single pulse by the electroporator set for a peak discharge of 1.6
kV, 25 Ohm and 25 AF, to give a pulse with a time constant of ¨300 As. After
electroporation, cells were diluted in 4.5 mL of SDM-79 medium and
incubated overnight without selection. Subsequently, the culture was diluted
serially into 24 wells of a microtiter plate using 4.5 mL conditioned SDM-79
medium containing 30 Ag mL1 hygromycin. Antibiotic-resistant cells were
detectable after about 8 days. To prepare conditioned medium, the supernatant
obtained from a procyclic culture in the exponential growth phase (7–9  106
cells mL1) was filter sterilized and stored for a few weeks at 4 -C or frozen.
Following transfection (done in triplicate for each DNA construct) and
selection of positive clones, correct integration of RNAi constructs into the
genome of bloodstream and procyclic forms was checked by PCR amplification
of the hygromycin resistance gene. Positive clones were stored at 80 -C in
HMI-9 or SDM-79 medium containing 12 or 10% glycerol for bloodstream and
procyclic forms, respectively.
The expression of double-stranded RNA was induced by addition of
tetracycline to the cultures at a concentration of 0.25 Ag mL1 for bloodstream-
form trypanosomes and 5.0 Ag mL1 for procyclic forms. Cultured cells were
serially diluted each 24 h to 2  105 cells mL1 and 106 cells mL1 for
bloodstream and procyclic form trypanosomes, respectively.
2.6. Subcellular fractionation by treatment of cells with digitonin
Procyclic trypanosomes (108–109 cells) were taken from either a culture not
induced for RNAi or an induced culture, 24 or 48 h after tetracycline addition.
The cells were centrifuged, washed twice in an ice-cold buffer containing 25 mM
HEPES, pH 7.4, 250 mM sucrose and 1 mM EDTA, and then resuspended at >1
mg protein mL1 in 0.5 mL of the same buffer containing a complete protease
inhibitor cocktail (Roche Applied Science). Subsequently, variable amounts of
the detergent digitonin [final concentration between 0 and 1 mg (mg of
protein)1] were added to aliquots of the cell suspensions (each containing 100
Ag of protein), followed by 0.2 mLHBSS buffer (Invitrogen) and incubated for 4
min. After centrifugation of the suspensions (12,000g for 2 min), 0.15 mL of
the supernatant was taken and kept on ice for Western blot analysis of proteins
released from the different cell compartments, or stored at 20 -C. As controls
(no protein release and release from all compartments, respectively) were taken
cells not treated with digitonin and cells to which 0.02% Triton X-100 (final
concentration) had been added to assure complete protein release due to full
disruption of plasma membrane and all organellar membranes.
2.7. Protein measurements, SDS/PAGE, Western blot analysis
Protein concentrations were determined using the Bio-Rad (USA) protein
assay, based on the Coomassie Blue-binding procedure [34], using bovine serum
albumin as a standard. SDS-PAGE was carried out by the Laemmli method [35].
After electrophoresis, gels were either stained with Coomassie Brilliant Blue, or
used for immunoblotting according to a standard procedure [36], using a
polyvinylidene difluoride membrane (Roche Applied Science). For immunode-
tection of proteins, primary antibodies were diluted in PBS, pH 7.3, containing
0.1% Tween 20 and 5% (w/v) low-fat milk powder. The secondary antibodies,
anti-(mouse IgG) or anti-(rabbit IgG) conjugated to horseradish peroxidase
(Rockland Immunochemicals) were diluted 1:40,000 and visualised with the
ECLWestern blotting system, a luminol-based system (Amersham Biosciences).
The primary antibodies used were mouse anti-His (1:20,000), or the following
antisera raised in rabbits against purified proteins (either natural proteins purified
from bloodstream-form trypanosomes as described [37], or recombinant proteins
purified from E. coli): anti-aldolase (ALD), 1:200,000; anti-triosephosphate
isomerase (TIM), 1:10,000; anti-glycosomal glyceraldehyde-3-phosphate dehy-
drogenase (gGAPDH), 1:100,000 [38–40].
2.8. Immunofluorescence studies
Procyclic trypanosomes (105–106 cells) were washed twice in ice-cold
phosphate-buffered saline (PBS), pH 7.3, fixed with 6% formaldehyde in PBS
. 1. Multiple alignment of PEX6 amino-acid sequences. The trypanosomatid sequences are compared with sequences with confirmed PEX6 activity. The Walker A and B motifs of the two AAA domains, D1 and
are indicated as: AD1., BD1 o, AD2 r, and BD2 j. The AAA signature is underlined. Conserved residues are given against a black background, residues at positions with conservative substitutions are in bold and
xed. Database accession numbers for the trypanosomatid sequences have been described in the main text. Other sequences used in the alignment, with their accession codes for the Swiss-Prot database are: Homo
iens (Q13608), Saccharomyces cerevisiae (P33760) and Yarrowia lipolytica (P36966). The figure was produced with the program ESPript 2.2 (http://espript.ibcp.fr/ESPript/cgi-bin/ESPript.cgi).
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H. Krazy, P.A.M. Michels / Biochimica et Biophysica Acta 1763 (2006) 6–1710for 10 min, permeabilized by treatment with 1% Triton X-100 for 10 min. After
spreading the trypanosomes on poly-l-lysine-coated slides, they were
incubated for 45 min in PBS containing 5% BSA at 37 -C, followed by
incubation in PBS containing 2% BSA and the primary antisera: mouse
monoclonal anti-T. brucei gGAPDH [41] at 1:2700–3500 dilution and rabbit
polyclonal anti-T. brucei ALD (see above) at 1:1500. After washing with PBS,
cells were allowed to react with fluorescein-conjugated secondary antibodies (5
Ag mL1 Alexa Fluor 488 anti-mouse IgG and Alexa 568 anti-rabbit IgG-
Molecular Probes), washed again and mounted in Mowiol containing 2 AM
TO-PRO-3 (Molecular Probes) for DNA staining. Cells were visualised using a
Zeiss Axiovert microscope coupled to an MRC-1024 confocal scanning laser
imaging system (Bio-Rad).
3. Results and discussion
3.1. Analysis of the sequences of the T. brucei peroxin
homologues PEX6, PEX10 and PEX12
3.1.1. PEX6
A fragment homologous to mammalian and yeast PEX6 was
found in the T. brucei (strain TREU927/4) genome project
database, and the corresponding full-length gene of T. brucei
strain 427 was subsequently cloned and sequenced. The protein
encoded by the ORF is 982 amino acids long, has a molecularFig. 2. Multiple alignment of PEX10 amino-acid sequences. The trypanosomatid
conserved Cys and His residues of the RING motif C3HC4 in the C-terminal
transmembrane segments, predicted from the hydropathy character calculated with
residues are given against a black background, residues at positions with conserva
trypanosomatid sequences have been described in the main text. Other sequences use
sapiens (AB013818), Arabidopsis thaliana (Q9M400), S. cerevisiae (Q05568), H
ESPript 2.2.mass of 106.0 kDa and a pI value of 5.0 (calculated using the
computational tools available at http://us.expasy.org/). After
completion of our analysis, the near-complete genome se-
quence of T. brucei TREU927/4 and that of the related
trypanosomatid parasites Leishmania major and T. cruzi be-
came available in the GeneDB database (http://www.geneDB.
org/), and PEX6 homologues could be identified: T brucei,
accession code Tb05.6E7.930; L. major, LmjF16.0060; T.
cruzi, Tc00.1047053506947.40 and Tc00.1047053504251.9).
Further genomic searches proved that the T. brucei sequence
analyzed was indeed orthologous with PEX6 of other organ-
isms. The putative PEX6s of the two T. brucei strains differ in
six amino acids. An alignment of the three trypanosomatid
sequences with those of human and different yeasts is
presented in Fig. 1. The trypanosomatid sequences are 65–
76% identical to each other, but share only 32–34 and 34–
36% identity with the human and S. cerevisiae PEX6s,
respectively. PEX6, as well as PEX1, belongs to the AAA+
protein family (ATPases associated with various cellular
activities). Members of this family are characterized by the
presence of one or more AAA modules, a conserved module of
220–250 amino acids responsible for ATPase activity [42,43].sequences are compared with sequences with confirmed PEX10 activity. The
region are marked by j, the PEX10 signature is indicated by r. The two
the algorithm according to Kyte and Doolittle [57], are underlined. Conserved
tive substitutions are in bold and boxed. Database accession numbers for the
d in the alignment, with their accession codes for the Swiss-Prot database are: H.
ansenula polymorpha (Q00940). The figure was produced with the program
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trypanosomatid ones three parts can be distinguished: an N-
terminal region (N, residues 1–¨400) and two AAA domains
(denoted D1, approximately residues 400–640 and D2,
approximately 640–980, respectively). The N-terminal domain
does not match with other known structures. AAA module D2
is relatively well conserved, and always possesses intact
Walker motifs A and B (GPPGCGKT and DELD, respectively;
Fig. 1) essential for nucleotide binding and hydrolysis. In
contrast, module D1 of all PEX6 homologues is only a weakly
conserved AAA cassette and its Walker motifs may contain
substitutions or even not be recognizable as is the case in the
trypanosomatid sequences (Fig. 1), strongly suggesting that
this module, at least in some species, may be incapable of
binding and/or hydrolyzing ATP. It has been shown that PEX6
of mammalian cells and different yeasts form a dynamic
hetero-oligomeric complex with PEX1, also structurally
organized as N/D1/D2 [44–46]. This interaction is mediated
by the D1 domain of both peroxins, but requires ATP
hydrolysis by domain D2 [47]. Moreover, it has been shown
for S. cerevisiae that PEX6 is recruited to the peroxisomal
membrane by the integral membrane protein PEX15 [48]. This
PEX6 binding occurs through its domain N and requires ATP
binding by PEX6. In mammalian peroxisome biogenesis, aFig. 3. Multiple alignment of PEX12 amino-acid sequences. The trypanosomatid
conserved Cys residues of the RING motif C3HC4 in the C-terminal region are ma
character calculated with the algorithm according to Kyte and Doolittle [57], are un
positions with conservative substitutions are in bold and boxed. Database accession n
Other sequences used in the alignment, with their accession codes for the Swiss-P
(Q04370), Pichia pastoris (Q01961) and Caenorhabditis elegans (Q19189). The fisimilar function of recruitment of a PEX1–PEX6 complex at
the mammalian membrane has been proposed for PEX26,
which binds directly to PEX6, involving the N-terminal
domains of both peroxins, and indirectly to PEX1 [49,50].
Also, PEX1 orthologues have recently been identified in the
trypanosomatid databases, each of them having the typical
PEX1/PEX6 domain organization: N/D1/D2, and with the D2
domain better conserved than D1 and theWalker A and Bmotifs
only being fully present in D2 (Tb04.2L9.350; LmjF34.3520,
Tc00.1047053505989.74 and Tc00.1047053508693.90). How-
ever, PEX1 is less conserved than PEX6: the trypanosomatid
sequences share only 49–60% identity with each other, and a
mere 27–28 and 23% identity with the human and S. cerevisiae
PEX1s, respectively.
3.1.2. PEX10 and PEX12
PEX10 and PEX12 are, as PEX2, integral membrane proteins
possessing a zinc-binding FRING-finger_ domain which is
involved in the interaction with other peroxins [51–53].
Fragments of candidates for T. brucei PEX10 and PEX12 were
found in databases by homology searches and the corresponding
genes of T. brucei strain 427 were subsequently cloned and
sequenced. The cloned genes appeared indeed orthologues of
PEX10 and PEX12 from other organisms and code forsequences are compared with sequences with confirmed PEX12 activity. The
rked by j. The two transmembrane segments, predicted from the hydropathy
derlined. Conserved residues are given against a black background, residues at
umbers for the trypanosomatid sequences have been described in the main text.
rot database are: H. sapiens (O00623), A. thaliana (Q9M841), S. cerevisiae
gure was produced with the program ESPript 2.2.
Fig. 5. (A) Northern blot analysis of total RNA purified from procyclic
trypanosomes before (0 h) and after (24 h and 48 h) induction of RNAi targeted
against PEX10, PEX12 and PEX6. The left panel shows the depletion of the
respective peroxin mRNAs, the right panel presents the data for a not-targeted
control transcript (enolase). Each lane contained 10 Ag of total RNA. (B)
Western blot analysis of lysates from procyclic trypanosomes. The lanes
contain each 10 Ag of protein from trypanosomes of the wild-type T. brucei 449
cell line, or the PEX6 RNAi cell line before (0 h) and after (24 h and 48 h)
induction.
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calculated molecular masses of 32.9 and 43.1 kDa and pI values
of 8.8 and 8.3. The proteins of the different trypanosomatids
appeared later also in the GeneDB databases with the following
accession codes: PEX10 T. brucei, Tb03.48O8.510 (with two
residues differing between strains TREU927/4 and 427), L.
major LmjF25.2290; T. cruzi Tc00.1047053508479.190;
PEX12 T. brucei, Tb10.61.0440 (one residue difference between
the two strains), L. major, LmjF19.1250; T. cruzi, Tc00.
1047053503809.20 and Tc00.1047053503641.19. Figs. 2 and
3 show alignments of the trypanosomatid putative PEX10 and
PEX12 sequences with the sequences of corresponding proteins
with confirmed peroxin activity from various other organisms.
For PEX10, the trypanosomatid sequences are 53–65%
identical to each other, but display only 26–28 and 25–26%
identity with their human and S. cerevisiae orthologues,
respectively. For PEX12, these values are 40–57% identity
between trypanosomatids, and 18–20% and 13–17% between
trypanosomatids and human and S. cerevisiae, respectively.
The sequences of both T. brucei PEX10 and PEX12 contain
two predicted hydrophobic transmembrane segments, similar to
their counterparts from other organisms, and in line with earlier
studies indicating that the N-terminal and C-terminal parts of
these proteins are exposed to the cytoplasm. The C-terminal
parts contain the RING-finger motifs. As in the peroxins of other
organisms, the trypanosomatid PEX10 contains a perfectlyFig. 4. Schematic representation of the linearized constructs prepared for the creat
PEX6, PEX10 and PEX12. The basis of the construct is the vector pHD677 [27]. FrR
vector’s unique NotI site used for its linearization; PARP, tetracycline-inducible PA
repressor bound to the operator of the promoter; FSense_ and Fantisense_ represen
inverted repeat in the polylinker of the vector pHD677, as described in Materials
expression site; HYG, hygromycin resistance gene.conserved C3HC4 consensus (C–X2–C–X(9–39)–C–X(1–3)–
H–X(2–3)–C–X2–C–X(3–47)–C–X2–C, [54]), whereas the
motif in PEX12 deviates from the consensus by the absence of
two of the seven Cys residues and the His (Figs. 2 and 3).
Furthermore, the putative trypanosomatid PEX10s have in the
N-terminal part a peptide sequence (TLGQEFC) very similar to
a motif conserved in all other known PEX10s (TLGEEYV). The
function of this motif is still unknown. All these similarities withion of stable transgenic T. brucei cell lines for tetracycline-inducible RNAi of
NA_ represents the targeting sequence of the intergenic rRNA region, with the
RP (Fprocyclic acidic repetitive protein_) promoter; black circles, tetracycline
t the PEX6, PEX10 and PEX12 gene fragments amplified and inserted as an
and methods; VSG, constitutive promoter of a FVariant Surface Glycoprotein_
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of similarities highlighted in Figs. 2 and 3, strongly suggest that
the putative trypanosomatid PEX10 and PEX12 are true
peroxins involved in glycosome biogenesis.
3.2. Knock-down of PEX6, PEX10 and PEX12 expression by
RNAi leads to arrest of cell growth
Bloodstream and procyclic T. brucei 449 cell lines were
prepared for tetracycline-inducible expression of double-
stranded RNA corresponding to either PEX6, PEX10 or
PEX12 (Fig. 4). To this end, DNA constructs, which also
directed the constitutive expression of the hygromycin resis-
tance marker, were created and stably integrated in the T.
brucei genome, in an intergenic region of a ribosomal RNA
gene array.Fig. 6. Effect of the intracellular depletion of different peroxins by RNAi on the grow
mRNAs targeted by RNAi were for PEX6 (panels A and D), PEX10 (panels B and
numbers. The growth of trypanosomes transfected with a plasmid producing double-
in the absence (0) or presence (r) of the RNAi inducer tetracycline (0.25 Ag mL1 fo
t = 0 onward.The efficiency of mRNA destruction by RNAi in procyclic
cells was checked by Northern blot analysis. The RNA levels
in each of the cell lines were determined before induction and
24 and 48 h after tetracycline addition to the cultures. In Fig.
5A, it is shown that 24 h after induction, the RNA levels have
decreased to 80%, 70% and 60% for PEX10, PEX12 and
PEX6, respectively, and became undetectable after 48 h. The
level of a control RNA, for the glycolytic enzyme enolase
(ENO), remained unaltered. At the protein level too, a
significant decrease could be observed in the case of PEX6,
for which an antiserum had been raised (Fig. 5B), whereas the
levels of ENO and pyruvate kinase (PYK), taken as control
proteins, were not affected. Using this same antiserum, it was
observed that the expression levels of PEX6 were similar in
wild-type bloodstream and procyclic T. brucei 449 cells (data
not shown).th of bloodstream form (left panels) and procyclic (right panels) T. brucei. The
E) and PEX12 (panels C and F). Shown are the 10log values of cumulative cell
stranded RNA to decrease specific PEX levels was determined for cells cultured
r bloodstream-form trypanosomes and 5.0 Ag mL1 mg for procyclic cells) from
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growth of trypanosomes was studied for both the bloodstream
and procyclic-form cell lines. In the bloodstream forms,
tetracycline addition resulted in reduction of cell numbers
already within 24 h for PEX10 depletion, and 24–48 h for
PEX6 and PEX12 (Fig. 6, left panel). In each case, cell
density continued to decline for several days, but increased
again after 4 to 5 days, eventually leading to the original
growth rate, possibly due to the emergence of mutated
revertants that escaped RNAi control, a phenomenon well
known in trypanosomes, particularly bloodstream forms
[55,56]. In procyclic trypanosomes, the effect on growth
was less severe, similarly to what has been reported before for
PEX2 and PEX14 [17,26]. A decrease in cell growth was
only visible after 2 to 3 days (Fig. 6, right panel). For PEX10
and PEX12 cell lines, slow growth continued, until after 8 to
10 days, cells started dying. For the PEX6 cell line, growth
arrest occurred earlier. Cells induced for depletion of PEX12
by RNAi showed a distinct phenotype: they stopped moving,
ballooned and formed aggregates before dying. Similar, albeit
less pronounced changes were observed for cells in which
PEX10 was targeted by RNAi. No distinctive morphological
phenotype was visible in trypanosomes in which RNAi was
induced for PEX6.
3.3. Destruction of mRNAs of PEX6, PEX10 and PEX12 by
RNAi leads to incomplete compartmentation of glycosomal
enzymes
To prove that the cloned genes are indeed peroxins
involved in the transport of proteins from their site of
synthesis, the cytosol, into the glycosomal matrix, weFig. 7. Subcellular fractionation by treatment of cells with digitonin. Intact procyclic
PYK, ALD, TIM and gGAPDH from the cells was assayed after centrifugation of th
the resulting supernatants. The subcellular distribution of enzymes is shown for tryp
PEX12 RNAi (C), before (0 h) and after (24 h and 48 h) the addition of the RNA
banding pattern at the blot 48 h after RNAi induction (not shown) was identical toexamined how the RNAi-induced degradation of their
mRNAs affected the compartmentation of glycosomal
enzymes with different PTS: the PTS1 protein gGAPDH,
the PTS2 protein ALD, and TIM that does not have a
recognizable PTS1 or PTS2 but possibly enters the glyco-
some by forming a heteromeric complex with a PTS1 or
PTS2 protein [6]. The subcellular distribution of these
enzymes, and that of the cytosolic marker enzyme PYK,
was studied by treating non-induced procyclic cells, and
cells cultured for 24 and 48 h in the presence of the inducer
tetracycline, with increasing concentrations of digitonin. This
detergent forms insoluble complexes with sterols, thus
permeabilizing the plasma membrane with its relatively high
sterol content at lower concentration than the glycosomal
membrane that is relatively poor in sterols. Therefore,
enzymes sequestered in glycosomes will only be released
from the cells at higher concentrations than enzymes present
in the cytosol. Fig. 7, panels A, B and C, show how RNAi-
induced depletion of PEX6, PEX10 and PEX12, resulted in
partial mis-localization of all three types of glycosomal
enzymes. The digitonin-dependent differential appearance of
enzymes outside the cells, as assayed by Western blotting,
was affected by RNAi. Whereas in non-induced cells only
the cytosolic PYK was released at low digitonin concentra-
tion [0.2 mg (mg protein)1], contrary to the glycosomal
enzymes whose release required 0.7 mg digitonin (mg
protein)1, RNAi induction resulted in release of a part of
the glycosomal proteins too at low detergent concentrations.
These experiments show that, in the RNAi-treated trypano-
somes, part of the ALD, gGAPDH and TIM is present in
the cytosol. For each of the three cell lines similar, partial
relocation of PTS1, PTS2 and I-PTS proteins from glyco--form T. brucei cells were incubated with digitonin as indicated. The release of
e treated cell suspensions and the preparation of Western blots of the proteins in
anosomes of the cell lines PEX6 RNAi (panel A), PEX10 RNAi (panel B) and
i inducer tetracycline (Tet) at a concentration of 5.0 Ag mL1. For PEX12 the
that after 24 h.
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quantitative differences between different experiments and
between the proteins within each experiment (gGAPDH not
shown for PEX6, ALD not for PEX10, TIM not for
PEX12). This relocated fraction of matrix proteins presum-
ably represents newly synthesized protein that could not be
imported into glycosomes, and consequently, these data may
be considered as strong evidence that indeed the three
cloned genes encode the authentic T. brucei peroxin
homologues. Similar experiments proved to be difficult to
perform with bloodstream-form trypanosomes, where cellsFig. 8. Effect of peroxin depletion on the distribution of glycosomal proteins of
procyclic-form T. brucei, as determined by immunofluorescence. Shown is the
relocation of ALD and gGAPDH in cell lines in which PEX6 (A), PEX10 (B),
and PEX12 (C) was targeted by RNAi. Procyclic trypanosomes were grown in
the absence or presence (for 24 or 48 h) of 5.0 Ag mL1 of the RNAi inducer
tetracycline, as indicated. DNA is stained blue with TO-PRO-3. The series
panels at the left show the images of trypanosomes obtained by transmission
microscopy, in combination with TO-PRO staining. The panels at the right
present the merged images of the ALD, gGAPDH and TO-PRO staining. (For
interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)are more rapidly killed after RNAi induction because the
mis-localization of already minor amounts of glycolytic
enzymes is much more detrimental than for procyclic cells
[4,17,21,22].
To further study the effect of peroxin depletion on import
of glycosomal matrix proteins and glycosome morphology in
procyclic trypanosomes, immunofluorescence experiments
were performed using confocal microscopy. Using double
labelling, ALD and gGAPDH co-localized as a congruent
punctuate pattern in the cytoplasm of non-induced cell lines
for RNAi of PEX6, PEX10 and PEX12 (Fig. 8A–C, panels
labelled -Tet), similar as found in non-transfected cells (not
shown) and characteristic of a glycosomal localization
[17,26]. In contrast, in the PEX10 and PEX12 RNAi cell
lines a diffuse fluorescence labelling along the parasite body
was observed for both ALD and gGAPDH, already 24 h after
addition of tetracycline (Fig. 8B and C, respectively). After
48 h, the diffuse fluorescence was even more pronounced.
These results corroborate the cytosolic mis-localization of
glycosomal enzymes as observed in the fractionation studies.
In the case of the PEX6 RNAi cell line, induction by
tetracycline for 24 h and 48 h showed the same diffuse
pattern for gGAPDH as in the other cell lines, but for ALD
clusters of bright punctuate structures remained visible in
addition to cytoplasmic staining (Fig. 8A). Relocalization of
ALD to the cytoplasm had occurred, but to a lesser extent
than for gGAPDH. At present, an explanation for this
quantitative difference is not known.
The results of the immunofluorescence experiments and
cell fractionation by digitonin titration demonstrate that the
three identified T. brucei genes code for true peroxins. They
are involved in glycosome biogenesis; their expression is
essential for proper compartmentation of glycosomal matrix
proteins. Together, the experiments presented in this paper
show that RNAi-specific depletion of the transcripts of
PEX6, PEX10 and PEX12 in trypanosomes is directly
correlated with reduction of the level of these proteins
(only proved for PEX6), mis-localization of glycosomal
matrix proteins and growth defects.
The observation that each of the three peroxins described
in this paper is essential for the trypanosome, together with
the low level of sequence conservation between the parasite
peroxins and the corresponding proteins in the human host,
makes them potentially good targets for trypanocidal drugs.
Such drugs could be compounds that disrupt specific
interactions with other peroxins involved in glycosome
biogenesis without interfering with peroxisome formation
in human cells.
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